Sanuwave Health Q1 Earnings Call Highlights

02:10pm, Wednesday, 13'th May 2026
Sanuwave Health NASDAQ: SNWV reported record first-quarter revenue and rising consumables utilization, while management said the advanced wound care market began to recover after a difficult start to
SANUWAVE Health, Inc. (SNWV) Q1 2026 Earnings Call Transcript
Sanuwave Health Inc. (SNWV) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to a loss of $0.66 per share a year ago.
Q1 2026 revenues were  $9.6 million , up 3.1% from $9.3 million in Q1 2025. This represents the highest Q1 quarterly revenues in Company history.
EDEN PRAIRIE, Minn., May 06, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will
Sanuwave Health (SNWV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ayr Wellness (OTCMKTS:AYRWF - Get Free Report) and Sanuwave Health (NASDAQ: SNWV - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two busines
On April 10, 2026, SANUWAVE Health Inc (SNWV) shares fell 7.2% to a current price of $16.84. The stock has experienced significant volatility, trading within a
Sanuwave Health (NASDAQ: SNWV - Get Free Report) and INLIF (NASDAQ: INLF - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses b
SANUWAVE Health, Inc. (SNWV) Q4 2025 Earnings Call Transcript
Q4 2025 revenues were  $13.4 million , up 29.7% from Q4 2024. This was an all-time quarterly record for the Company.
EDEN PRAIRIE, Minn., March 20, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, wi
Profitability This table compares Arch Therapeutics and SANUWAVE Health's net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Arch Therapeutics -8,257.70%
Sanuwave Health Reports Preliminary Q4 2025 Revenue of $13.3–$13.4 Million, Up 29–30% Year-over-Year; Achieves Record Quarterly and Full-Year Revenue
InfuSystem (NYSE: INFU - Get Free Report) and SANUWAVE Health (OTCMKTS:SNWV - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two compan
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE